Skip to content

Clinical trials

Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Country / region: Belgium Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20055
20071
20092
20102
20111
20121
20135
20143
20155
20161
20174
20182
20194
20203
20211
20223
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Recruiting11
Terminated8
Active, not recruiting6
Unknown status5
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC10
Novartis Pharmaceuticals7
Kiadis Pharma5
Princess Maxima Center for Pediatric Oncology4
Amgen3
Bristol-Myers Squibb3
Charite University, Berlin, Germany2
Janssen Research & Development, LLC2
AbbVie1
Amgen Research (Munich) GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma56
Leukemia18
Leukemia, Myeloid, Acute16
Recurrence12
Burkitt Lymphoma11
Leukemia, Lymphocytic, Chronic, B-Cell10
Lymphoma10
Multiple Myeloma10
Myelodysplastic Syndromes10
Lymphoma, Non-Hodgkin9

Trials

Showing 76 to 56 of 56. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.